- BNF:
- 11.6
- Status:
- Grey - after consultant/specialist initiation
- Decision Date:
- None
Comments
GREY after consultant/specialist initiation:
- 3rd line prostaglandin analogue (100micrograms/ml (3ml). (Decision date - November 2015).
- 2nd line preservative free prostaglandin analogue (3ml). Cost effective to prescribe generically. (Decision date - July 2022).
Grey Drug Classifications
- 5: Less cost-effective than current standard therapy
search again